The article explains that producing medical gloves in the U.S. is difficult because the industry relies on natural rubber and established Southeast Asian manufacturing, while domestic production faces high labor, regulatory and capital costs and lacks the economies of scale needed to compete. Supply-chain complexity, strict quality/contamination controls and strong import competition mean reshoring is costly and slow despite heightened attention since COVID.